Brain cancer map uncovers thousands of hidden targets for personalized immunotherapies

Wait 5 sec.

Researchers from the Clinical Neuroscience Consortium (CNC), a collaborative platform jointly established by the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and Queen Mary Hospital, in collaboration with the Hong Kong Genome Institute (HKGI), have developed the most comprehensive map to date of isoform diversity in glioblastoma, the most common and aggressive form of brain cancer in adults.